HBI
50
-6
QCOM
49
-4
ILMN
26
-10
PAYX
32
-13
XRX
44
-4
WHR
57
-8
SO
39
-9
DVA
59
-2
DAL
50
-8
AA
34
-6
DOW
43
-3
TGNA
35
-10
DNB
66
-4
VTR
40
-6
URBN
62
-6
PNC
45
-4
APD
37
-5
LOW
40
-8
GWW
46
-9
EQIX
53
-6
HBI
50
-6
QCOM
49
-4
ILMN
26
-10
PAYX
32
-13
XRX
44
-4
WHR
57
-8
SO
39
-9
DVA
59
-2
DAL
50
-8
AA
34
-6
DOW
43
-3
TGNA
35
-10
DNB
66
-4
VTR
40
-6
URBN
62
-6
PNC
45
-4
APD
37
-5
LOW
40
-8
GWW
46
-9
EQIX
53
-6
Financhill
Back

Virtus Investment Partners Vs. Viking Therapeutics Industry Stock Comparison

Buy
51

VRTS
Virtus Investment Partners

Last Price:
220.84
Seasonality Move:
2.15%
Sell
28

VKTX
Viking Therapeutics

Last Price:
38.24
Seasonality Move:
40.87%
Buy
51
Virtus Investment Partners (VRTS) is a Buy

Is Virtus Investment Partners a Buy, Sell or Hold?

  • The current Virtus Investment Partners [VRTS] share price is $220.92. The Score for VRTS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • VRTS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $38.28. The Score for VKTX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRTS Stock Price Chart

What is Virtus Investment Partners's stock price today?

  • The Virtus Investment Partners share price today is $220.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTS is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $38.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

VRTS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.31 Buy
Relative Strength Index (14 RSI): 31.19 Sell
Chaikin Money Flow: -43089 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (235.02 - 248.1) Sell
Bollinger Bands (100): (201.61 - 235.31) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.91 Sell
Relative Strength Index (14 RSI): 23.24 Sell
Chaikin Money Flow: -10764092 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.91 - 53.55) Sell
Bollinger Bands (100): (52.21 - 67.17) Sell

VRTS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 239.02 Sell
20-day SMA: 242.63 Sell
50-day SMA: 230.9 Sell
200-day SMA: 224.81 Sell
8-day EMA: 236.24 Sell
20-day EMA: 239.02 Sell
50-day EMA: 232.66 Sell
200-day EMA: 222.94 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.82 Sell
20-day SMA: 49.84 Sell
50-day SMA: 58.67 Sell
200-day SMA: 62.24 Sell
8-day EMA: 46.02 Sell
20-day EMA: 49.86 Sell
50-day EMA: 55.23 Sell
200-day EMA: 54.61 Sell

Virtus Investment Partners Earnings Growth & VRTS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.65 per share, and an increase next year of $3.52 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.

Virtus Investment Partners Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):